LRT Capital Management’s ResMed RMD Stock Holding History

LRT Capital Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,699	Closed	-$650K	–	116
2025 Q4	$650K	Sell	2,699 -1,281	-32%	-$328K	0.56%	64
2025 Q3	$1.09M	Sell	3,980 -590	-13%	-$161K	0.72%	54
2025 Q2	$1.18M	Buy	4,570 +115	+3%	+$27.4K	0.7%	49
2025 Q1	$997K	Buy	+4,455	New	+$1.04M	0.68%	50
2024 Q3	–	Sell	-1,287	Closed	-$246K	–	90
2024 Q2	$246K	Buy	+1,287	New	+$261K	0.23%	80
2023 Q1	–	Sell	-6,528	Closed	-$1.36M	–	77
2022 Q4	$1.36M	Sell	6,528 -176	-3%	-$38.7K	0.79%	39
2022 Q3	$1.46M	Sell	6,704 -419	-6%	-$95.4K	1%	39
2022 Q2	$1.49M	Buy	7,123 +2,351	+49%	+$501K	1.12%	33
2022 Q1	$1.16M	Sell	4,772 -8,125	-63%	-$1.97M	0.74%	41
2021 Q4	$3.36M	Buy	+12,897	New	+$3.35M	2.56%	17

Other funds holding RMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

LRT Capital Management's RMD Position: Q1 2026 in Review

LRT Capital Management sold out of ResMed (RMD) in Q1 2026, closing a stake of 2,699 shares — an estimated $650K sold.

LRT Capital Management first reported a position in RMD in Q4 2021 and held it in 10 quarters. The position peaked at $3.36M in Q4 2021. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

LRT Capital Management reported no remaining ResMed position as of Q1 2026 after selling out during the quarter.
LRT Capital Management sold 2,699 ResMed shares in Q1 2026, an estimated $650K.
LRT Capital Management first reported a position in ResMed in Q4 2021 and held it in 10 quarters.
LRT Capital Management's ResMed position peaked at $3.36M in Q4 2021.
938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on LRT Capital Management's 13F filing for Q1 2026, filed 15 May 2026.